Cao YW - Search Results

1

Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.

Liu PF, Cao YW, Jiang HP, Wang YH, Yang XC, Wang XS, Niu HT. Liu PF, et al. Among authors: cao yw. Med Oncol. 2014 Sep;31(9):21. doi: 10.1007/s12032-014-0021-9. Epub 2014 Aug 2. Med Oncol. 2014. PMID: 25085780

2

Proteomics research on muscle-invasive bladder transitional cell carcinoma.

Niu HT, Dong Z, Jiang G, Xu T, Liu YQ, Cao YW, Zhao J, Wang XS. Niu HT, et al. Among authors: cao yw. Cancer Cell Int. 2011 Jun 7;11(1):17. doi: 10.1186/1475-2867-11-17. Cancer Cell Int. 2011. PMID: 21645413 Free PMC article.

3

Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery.

Niu HT, Yang CM, Jiang G, Xu T, Cao YW, Zhao J, Wang XS. Niu HT, et al. Among authors: cao yw. J Cancer Res Clin Oncol. 2011 Aug;137(8):1273-82. doi: 10.1007/s00432-011-0995-z. Epub 2011 Jun 25. J Cancer Res Clin Oncol. 2011. PMID: 21706132

4

Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity.

Liu PF, Wang YH, Cao YW, Jiang HP, Yang XC, Wang XS, Niu HT. Liu PF, et al. Among authors: cao yw. Oncol Rep. 2014 Oct;32(4):1489-96. doi: 10.3892/or.2014.3340. Epub 2014 Jul 18. Oncol Rep. 2014. PMID: 25050759

5

Warburg effect or reverse Warburg effect? A review of cancer metabolism.

Xu XD, Shao SX, Jiang HP, Cao YW, Wang YH, Yang XC, Wang YL, Wang XS, Niu HT. Xu XD, et al. Among authors: cao yw. Oncol Res Treat. 2015;38(3):117-22. doi: 10.1159/000375435. Epub 2015 Feb 19. Oncol Res Treat. 2015. PMID: 25792083 Review.

6

Bladder Tumor Heterogeneity: The Impact on Clinical Treatment.

Chen C, Qi XJ, Cao YW, Wang YH, Yang XC, Shao SX, Niu HT. Chen C, et al. Among authors: cao yw. Urol Int. 2015;95(1):1-8. doi: 10.1159/000370165. Epub 2015 Mar 21. Urol Int. 2015. PMID: 25823547 Review.

7

T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.

Yang M, Yu Q, Liu J, Fu W, Cao Y, Yu L, Shao S, Wang X, Niu H, Wang Y. Yang M, et al. J Surg Oncol. 2015 Sep;112(4):430-5. doi: 10.1002/jso.24012. Epub 2015 Aug 11. J Surg Oncol. 2015. PMID: 26265374

8

Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment.

Hu KY, Wang de G, Liu PF, Cao YW, Wang YH, Yang XC, Hu CX, Sun LJ, Niu HT. Hu KY, et al. Among authors: cao yw. Oncol Rep. 2016 Aug;36(2):945-51. doi: 10.3892/or.2016.4884. Epub 2016 Jun 16. Oncol Rep. 2016. PMID: 27373212

9

Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo.

Liu W, Cao Y, Fernández MI, Niu H, Xiu Y. Liu W, et al. Int Urol Nephrol. 2011 Sep;43(3):721-7. doi: 10.1007/s11255-010-9866-9. Epub 2010 Nov 12. Int Urol Nephrol. 2011. PMID: 21072592

10

Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.

Wang YH, Cao YW, Yang XC, Niu HT, Sun LJ, Wang XS, Liu J. Wang YH, et al. Among authors: cao yw. Asian Pac J Cancer Prev. 2014;15(3):1321-6. doi: 10.7314/apjcp.2014.15.3.1321. Asian Pac J Cancer Prev. 2014. PMID: 24606459 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters